| Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484) |
|---|
| 03/11/2009 | CN101380350A Chinese caterpillar fungus heart-resurrection compound capasules |
| 03/11/2009 | CN101380343A Extraction from mixture of angelica and ligusticum wallichii rhizome and extraction method |
| 03/11/2009 | CN101380324A Pharmaceutical composition containing lacidipine and atorvastatin and preparation method and use thereof |
| 03/11/2009 | CN101380322A A new use for deferiprone |
| 03/11/2009 | CN101380312A Carvedilol enteric preparation and preparation method thereof |
| 03/11/2009 | CN101380129A Beverage for reducing weight, protect and strengthen health and production technique thereof |
| 03/11/2009 | CN100467494C Organic medicine and betacyclodextrin derivative and preparation process thereof |
| 03/11/2009 | CN100467469C A2b adenosine receptor antagonists |
| 03/11/2009 | CN100467463C Pyrazolyl indolyl derivatives as PPAR activators |
| 03/11/2009 | CN100467461C N-oxyde of N-phenyl-2-pyrimidine-amine derivatives |
| 03/11/2009 | CN100467454C Substituted spirobenzazepines |
| 03/11/2009 | CN100467450C Anthranilic acid amides and pharmaceutical use thereof |
| 03/11/2009 | CN100467448C Acid-group-substituted diphenylazetidinones, process for their preparation, medicaments comprising these compounds, and their use |
| 03/11/2009 | CN100467443C 6-(aryl-amido or aryl-amidomethyl)-naphthalen-2-yloxy-acidic derivatives as inhibitors of plasminogen activator inhibitor type-1 (PAI-1) |
| 03/11/2009 | CN100467441C Aminomethyl-phenyl-cyclohexanone derivatives |
| 03/11/2009 | CN100467060C Intratumorally administered lactoferrin in the treatment of malignant neoplasms diseases |
| 03/11/2009 | CN100467059C Use of lactoferrin in the treatment of malignant neoplasms diseases |
| 03/11/2009 | CN100467055C An external pharmaceutical for treatment of arrhythmia, coronary heart disease and angina pectoris |
| 03/11/2009 | CN100467036C Soft capsule of acetic acid of hawkthorn, and preparation method |
| 03/11/2009 | CN100467032C Medicinal bolus with functions of dilating vessels and removing blood stasis and its preparing process |
| 03/11/2009 | CN100467025C Use of asiaticoside or hydroxy asiaticoside in preparation of medicines for diseases of cardio-cerebral blood vessels |
| 03/11/2009 | CN100467023C Use of N-(3-methoxy-5-methyl pyrazine-2-group)-2-(4-[1,3,4-oxadiazole-2-group]phenyl) pyridine-3-sulfanilamide as anticarcinogen |
| 03/11/2009 | CA2638354A1 Association of an anti-atherothrombotic and an angiotensin converting enzyme inhibitor |
| 03/10/2009 | US7501516 3-Cyanoquinolines 4-substituted by a methylenedioxyphenyl group that is attached by a methylene, oxy, thio, sulfinyl, sulfonyl or amino group; antitumor agents |
| 03/10/2009 | US7501437 2-[(2-Isopropylsulfanyl-3-oxo-spiro[3.5]non-1-en-1-yl)amino]-3-[4-([2,7]naphthyridin-1-ylamino)phenyl]propanoic acid; compounds can inhibit the binding of integrins to their ligands and are of use in the prophylaxis and treatment of immuno or inflammatory disorders |
| 03/10/2009 | US7501431 Physiologically active substances PF1270A, B and C substances |
| 03/10/2009 | US7501425 e.g. 1-Methyl-7-[4-(pyrazol-1-yl)phenylamino]pyrimido[4,5-d]pyrimidin-2(1H)-one; anticarcinogenic agents; restenosis, angiogenesis and atherosclerosis |
| 03/10/2009 | US7501417 Aminocarbonyl-derivatives as novel inhibitors of histone deacetylase |
| 03/10/2009 | US7501412 e.g. 4-(1-(2-hydroxyethyl)piperidin-4-yl)-2H-isoquinolin-1-one; poly(ADP-ribose)polymerase inhibitor; nicotinamide nucleotide (NAD) substrate; acute cerebral infarction |
| 03/10/2009 | US7501407 Amide substituted pyrimidine compound; antiarthritic agents; antiischemic agents; antidiabetic agents; inflammatory bowel disease; antiproliferative agents; antiallergens |
| 03/10/2009 | US7501403 Bile acid or bile salt fatty acid conjugates |
| 03/10/2009 | US7501399 Immunoeffector compounds |
| 03/10/2009 | US7501263 Nucleic acids encoding mammalian T-type calcium channels |
| 03/10/2009 | US7501115 Providing a tissue removal system; removing adipose tissue from a patient using the tissue removal system, the adipose tissue having a concentration of stem cells; processing at least a part of the adipose tissue to obtain a concentration |
| 03/10/2009 | CA2468649C Adenosine a2a receptor antagonists |
| 03/10/2009 | CA2415068C Oral compositions comprising antimicrobial agents |
| 03/10/2009 | CA2368418C 1-arenesulfonyl-2-aryl-pyrrolidine and piperidine derivatives for the treatment of cns disorders |
| 03/10/2009 | CA2300049C Compositions, apparatus and methods for facilitating surgical procedures |
| 03/10/2009 | CA2289851C Compounds and methods for the inhibition of the expression of vcam-1 |
| 03/05/2009 | WO2009028707A1 Inhibitor of ischemic disorders |
| 03/05/2009 | WO2009027965A1 Transition metal complexes of corroles for preventing cardiovascular diseases or disorders |
| 03/05/2009 | WO2009027753A1 Composition and method inhibiting inflammation |
| 03/05/2009 | WO2009027392A1 4-(4-pyridinyl)-benzamides and their use as rock activity modulators |
| 03/05/2009 | WO2009027264A1 Benzimidazole derivatives used as fxr agonists |
| 03/05/2009 | WO2009027077A2 5-arylalkylidene-2-arylalkyl-thiazol-4-one derivatives as inhibitors of 5-lipoxygenase and uses thereof |
| 03/05/2009 | WO2009026940A1 Use of compounds derived from cycloheximide for the treatment or prevention of, in particular, ischaemias and cardiopathies |
| 03/05/2009 | WO2009026817A1 Compounds and composition used for inhibitting pge2 released from cmec |
| 03/05/2009 | WO2009026717A1 Inhibitors of protein tyrosine kinase activity |
| 03/05/2009 | WO2009026697A1 A method of reducing a vasodilatory response using a guanylate cyclase pathway inhibitor or an h2o2 reducing agent |
| 03/05/2009 | WO2009026658A1 Ppar agonists |
| 03/05/2009 | WO2009026657A1 Flavonoid ppar agonists |
| 03/05/2009 | WO2009008009A4 Novel crystalline form b of carvedilol dihydrogen phosphate |
| 03/05/2009 | WO2009006732A9 Bifunctional fusion proteins of the alpha-melanocyte stimulating hormone (alpha-msh) and atrial natriuretic protein (anp) and uses in hypertension and acute kidney injury |
| 03/05/2009 | WO2008156828A8 Renin inhibitors |
| 03/05/2009 | WO2008156817A8 Renin inhibitors |
| 03/05/2009 | WO2008156685A3 Tendon stem cells |
| 03/05/2009 | WO2008153705A3 Methods of treating, diagnosing and detecting fgf21-associated disorders |
| 03/05/2009 | WO2008148849A8 Piperidine/piperazine derivatives |
| 03/05/2009 | WO2008108322A3 Composition and method for protecting mitochondria |
| 03/05/2009 | WO2007126365A8 Further medical uses of antisecretory protein |
| 03/05/2009 | US20090062876 Quantum dot labeled stem cells for use in providing pacemaker function |
| 03/05/2009 | US20090062401 Decaline-derived compounds as pharmaceutically active agents |
| 03/05/2009 | US20090062396 Novel Haloalkoxy-Substituted Salicylic Anilides |
| 03/05/2009 | US20090062395 Renin inhibitors for the treatment of hypertension |
| 03/05/2009 | US20090062384 Novel abietane diterpenoid compound, and composition comprising extract of torreya nucifera, or abietane diterpenoid compounds or terpenoid compounds isolated from them for prevention and treatment of cardiovascular disease |
| 03/05/2009 | US20090062369 Use of secretory phospholipase a2 (spla2) inhibitors to decrease spla2 levels |
| 03/05/2009 | US20090062358 Peroxisome proliferator activated receptor alpha agonists |
| 03/05/2009 | US20090062356 Substituted benzimidazole derivatives |
| 03/05/2009 | US20090062352 Deuterium-enriched amlodipine |
| 03/05/2009 | US20090062342 Amines |
| 03/05/2009 | US20090062300 Deuterium-enriched prazosin |
| 03/05/2009 | US20090062299 Deuterium-enriched doxazosin |
| 03/05/2009 | US20090062298 Deuterium-enriched sildenafil |
| 03/05/2009 | US20090062296 Nitrooxyderivatives of prostaglandin amides, e.g., N-(3-(nitrooxy)propyl) 1R-[1 alpha (Z),2 beta (R*),3 alpha ,5 alpha ]]-7-[3,5-dihydroxy-2-(3-hydroxy-5-phenylpentyl)cyclopentyl]-5-heptenamide; reduced side effects,wider pharmacological activity, enhanced tolerability, long-acting hypotensive activity |
| 03/05/2009 | US20090062294 Heteroaryl-substituted urea modulators of fatty acid amide hydrolase |
| 03/05/2009 | US20090062268 Novel inhibitors of poly(adp-ribose)polymerase (parp) |
| 03/05/2009 | US20090062260 Compounds and compositions as lxr modulators |
| 03/05/2009 | US20090062239 Thrombin receptor antagonists as prophylaxis to complications from cardiopulmonary surgery |
| 03/05/2009 | US20090062214 Left-Side Glucose Lipid a Analogue |
| 03/05/2009 | US20090062195 Kallikrein-Inhibitor Therapies |
| 03/05/2009 | US20090062192 Dimeric Peptide Agonists of the Glp-1 Receptor |
| 03/05/2009 | US20090061000 Pharmaceutical formulation use 030 |
| 03/05/2009 | US20090060953 Methods for using tetanus toxin for beneficial purposes in animals (mammals) |
| 03/05/2009 | US20090060943 Syndrome X Composition and Method of Lowering Blood Pressure and Glycemic Index |
| 03/05/2009 | US20090060942 Detoxification Composition and Method of Detoxifying the Body |
| 03/05/2009 | US20090060929 Gene therapy and vaccination; non-viral transfection complex of a nucleic acid, optionally, a lipid,a polycationic nucleic acid-binding component, and a cell surface receptor binding peptide of given sequence |
| 03/05/2009 | US20090060925 Rage Fusion Proteins and Methods of Use |
| 03/05/2009 | US20090060909 Antibody antagonists of ve-cadherin without adverse effects on vascular permeability |
| 03/05/2009 | US20090060900 Methods for Screening Compounds That Modulate Lipid Metabolism |
| 03/05/2009 | US20090060893 Methods for enlarging the diameter of a biological conduit in a human subject |
| 03/05/2009 | DE102007040336A1 Neue Inhibitoren der 5-Lipoxygenase und deren Verwendungen New inhibitors of 5-lipoxygenase and their uses |
| 03/05/2009 | CA2698552A1 Transition metal complexes of corroles for preventing cardiovascular diseases or disorders |
| 03/05/2009 | CA2697900A1 Inhibitor of ischemic disorders |
| 03/05/2009 | CA2697795A1 Inhibitors of protein tyrosine kinase activity |
| 03/05/2009 | CA2697709A1 Use of compounds derived from cycloheximide for treating or preventing, in particular, ischaemias and cardiopathies |
| 03/05/2009 | CA2697382A1 4-(4-pyridinyl)-benzamides and their use as rock activity modulators |
| 03/05/2009 | CA2697167A1 Benzimidazole derivatives used as fxr agonists |
| 03/04/2009 | EP2031057A1 SENSE OLIGONUCLEOTIDE CAPABLE OF CONTROLLING THE EXPRESSION OF iNOS AND COMPOSITION COMPRISING THE SAME |
| 03/04/2009 | EP2030968A2 Sulfur-containing compound, method of preparation and pharmaceutical uses thereof |
| 03/04/2009 | EP2029604A2 Aldosterone synthase and/or 11beta-hydroxylase inhibitors |